Meiva Turkey
Our Products
Mexiclen 125 g Amoxicillin Injection BP / 100 ml
PROPERTIES:
Upper respiratory tract infections, ottis media, acute and chronic bronchitis, typhoid and paratyphoid fever, Skin and soft issue infections, Septicaemia.
Contra-Indication
Amoxicillin is a penicilin and should not be given to penicillin-hypersensitive patients. Attention should be paidto possible cross-sensitivity with other beta-lactam antibiotics eg. Cephalosporins.
Mexiclen 250 g Amoxicillin Injection BP / 100 ml
PROPERTIES:
Upper respiratory tract infections, offis media, acute and chronic bronchitis, typhoid and paratyphoid fever, Skin and soft tissue infections, Septicaemia.
Contra-Indication
Amoxicilin is a penicillin and should not be given to penicilin-hypersensitive patients. Attention should be paidto possible cross-sensitvity with other beta-lactam anfibiotics eg. Cephalosporins.
Mexiclen 1 g Amoxicillin Injection BP / 1vial - 1 Ampoule
PROPERTIES:
Mexiclen 500mg Amoxicllin Capsules USP / 10x10 Capsule
PROPERTIES:
Mecam 7.5 Meloxicam / 1x10 Tablets
PROPERTIES:
Contraindications This medicinal product is contra-indicated in the following situations:
Third trimester of pregnancy (see section 4.6 ‘Pregnancy and lactation);
Children and adolescents aged under 16 years;
Hypersenstvity to meloxicam or to one of the excipients or hypersensitvity to substances with a similar action, e.g. NSAIDs, aspitin.
Meloxicam should not be given to patients who have developed signs of asthma, nasal polyps, angioneurotic oedera or urticara following
the administration of aspirin or other NSAIDs;
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy;
Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding);
Active intestinal inflammatory disease (Crohn’s disease, ulcerative colitis);
Severely impaired liver function;
Meloxicam is contraindicated in treatment of perioperative pain after coronary artery bypass surgery (CABG).
Mecam 15 Meloxicam / 1x10 Tablets
PROPERTIES:
Contraindications This medicinal product is contra-indicated in the following situations:
Third trimester of pregnancy (see section 4.6 ‘Pregnancy and lactation);
Children and adolescents aged under 16 years;
Hypersenstvity to meloxicam or to one of the excipients or hypersensitvity to substances with a similar action, e.g. NSAIDs, aspitin.
Meloxicam should not be given to patients who have developed signs of asthma, nasal polyps, angioneurotic oedera or urticara following
the administration of aspirin or other NSAIDs;
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy;
Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding);
Active intestinal inflammatory disease (Crohn’s disease, ulcerative colitis);
Severely impaired liver function;
Meloxicam is contraindicated in treatment of perioperative pain after coronary artery bypass surgery (CABG).
Mexiclen 500mg Amoxicllin Capsules USP / 10x10 Capsule
PROPERTIES:
Cipromev 500mg Ciprofloxacin / 1x10 Tablets
PROPERTIES:
Dexamev 8mg / 2ml / 1x2 Ml
PROPERTIES:
Loramev 10mg Loratadine Tablets BP / 3x10 Tablets
PROPERTIES:
Mekocin 500mg Amikacin Injection BP / 1x2 ml Ampoule
PROPERTIES:
Posology and method of administration
Amikacin sulphate injection may be given intramuscularly or intravenously.
Amikacin should not be physically premixed with other drugs, but should be administered separately according to the recommended dose and route.
The patient’s pre-treatment bodyweight should be obtained for calculation of correct dosage.
The status of renal function should be estimated by measurement of the serum creatinine concentration or calculation of the endogenous creatinine clearance rate. The blood urea nitrogen (BUN) is much less reliable for this purpose.
Reassessment of renal function should be made periodically during therapy.
Whenever possible, amikacin concentrations in serum should be measured to assure adequate, but not excessive levels. It is desirable to measure both peak and trough serum concentrations intermittently during therapy. Peak concentrations (30-90 minutes after injection) above 35 mcg/ml and trough concentrations (just prior to the next dose) above 10 mcg/ml should be avoided. Dosage should be adiusted as indicated. In patients with normal renal function, once-daily dosing may be used; peak concentrations in these cases may exceed 35 mcg/ml.
For most infections the intramuscular route is preferred, but in life-threatening infections, or in patients in whom intramuscular injection is not feasible, the intravenous route, either slow bolus (2 to 3 minutes) or infusion (0.25% over 30 minutes) may be used.
Mekocin 100mg Amikacin Injection BP / 1x2 ml Ampoule
PROPERTIES:
Medome 10 Domperidone Tablets BP / 30x10 Tablets
PROPERTIES:
Dexamev 8mg / 2ml / 1x2 Ml
PROPERTIES:
Cefomev 500mg Cefotaxime For Injection BP / 1 Vial & 1 Ampoule
PROPERTIES:
Megmanten 1.2g Amoxicllin & Potassium Clavulanate Injection BP / 1 Vial & 1 Ampoule
PROPERTIES: